Literature DB >> 3051084

Impaired beta-cell responses improve when fasting blood glucose concentration is reduced in non-insulin-dependent diabetes.

R E Ferner1, M D Rawlins, K G Alberti.   

Abstract

Pancreatic beta-cell responses to a controlled intravenous glucose stimulus in 18 untreated non-insulin-dependent diabetic patients were compared with those in seven healthy control subjects. The patients' first-and second-phase responses were only 10 to 20 per cent of those of the normal subjects. However, when normal subjects had been hyperglycaemic for two hours, their first-phase responses were similar to those of the patients. Six patients were subsequently treated by diet alone, six by diet and tolbutamide and six by diet and metformin. There was no improvement in first-phase responses after treatment, but second-phase responses doubled. Improved responses were seen with all treatments, and correlated with the fall in fasting blood glucose concentration during treatment. This study supports the view that hyperglycaemia impairs beta-cell function and suggests that first-phase responses are more sensitive to hyperglycaemia than second-phase responses.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3051084

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  9 in total

Review 1.  [Value of biguanide in therapy of diabetes mellitus].

Authors:  E Haupt; U Panten
Journal:  Med Klin (Munich)       Date:  1997-08-15

Review 2.  An energetic tale of AMPK-independent effects of metformin.

Authors:  Russell A Miller; Morris J Birnbaum
Journal:  J Clin Invest       Date:  2010-06-23       Impact factor: 14.808

Review 3.  Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus.

Authors:  Surapon Tangvarasittichai
Journal:  World J Diabetes       Date:  2015-04-15

Review 4.  Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

Authors:  Shelley R Salpeter; Elizabeth Greyber; Gary A Pasternak; Edwin E Salpeter
Journal:  Cochrane Database Syst Rev       Date:  2010-04-14

5.  Long-term effects of glipizide on insulin secretion and blood glucose control in patients with non-insulin-dependent diabetes mellitus.

Authors:  P O Bitzén; A Melander; B Scherstén; M Svensson; E Wåhlin-Boll
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

6.  No glucotoxicity after 53 hours of 6.0 mmol/l hyperglycaemia in normal man.

Authors:  H Flax; D R Matthews; J C Levy; S W Coppack; R C Turner
Journal:  Diabetologia       Date:  1991-08       Impact factor: 10.122

Review 7.  Problems and pitfalls of sulphonylurea therapy in older patients.

Authors:  D A Robertson; P D Home
Journal:  Drugs Aging       Date:  1993 Nov-Dec       Impact factor: 3.923

Review 8.  Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use.

Authors:  A Melander; P O Bitzén; O Faber; L Groop
Journal:  Drugs       Date:  1989-01       Impact factor: 9.546

9.  Antidiabetic activity of Chandraprabha vati - A classical Ayurvedic formulation.

Authors:  Manish M Wanjari; Sujata Mishra; Yadu Nandan Dey; Deepti Sharma; Sudesh N Gaidhani; Ankush D Jadhav
Journal:  J Ayurveda Integr Med       Date:  2016-09-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.